Weekly paclitaxel plus bevacizumab versus docetaxel as second- or third-line treatment in advanced non-squamous non–small-cell lung cancer: Results of the IFCT-1103 ULTIMATE study

Alexis B. Cortot, Clarisse Audigier-Valette, Olivier Molinier, Sylvestre Le Moulec, Fabrice Barlési, Gérard Zalcman, Patrick Dumont, Damien Pouessel, Claire Poulet, C. Fontaine-Delaruelle, Sandrine Hiret, A. Dixmier, P Renault, Catherine Becht, Olivier Raffy, C. Dayen, Julien Mazières, Éric Pichon, Alexandra Langlais, Franck Morin, Denis Moro‐Sibilot, Benjamin Besse